A Phase III Randomized, Double E-Blind, Placebo-Controlled Trial To Evaluate The Efficacy And Safety Of PRM-151 In Patients With Idiopathic Pulmonary Fibrosis

  • Chaaban, Said (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date10/28/212/28/22